Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion and the newly launched AYON Body Contouring System, announced the strategic appointments of two accomplished sales executives to its leadership team. These additions support the Company’s continued global expansion and the commercial launch of AYON, the industry’s first all-in-one surgical body contouring system.
Health Technology Insights: Delta Development Closes Series A3, Leads Prehospital Blood
John Featherstone has been named Vice President of North American Sales, bringing more than 20 years of experience in commercial leadership roles within the aesthetics and medical device industry. Most recently serving as Vice President of Global Sales and Marketing at Cytrellis Biosystems, Mr. Featherstone led high-growth initiatives and successful product launches at leading companies, including Cutera, Inc. and Cynosure. His proven ability to scale commercial operations and build high-performance teams will be instrumental as Apyx looks to accelerate adoption of both Renuvion and AYON across North America.
Simon Davies has been named Director of Internation Sales, Europe and Asia-Pacific, bringing three decades of global sales leadership and distribution development experience across Europe and Asia-Pacific. Having previously held executive roles at Hewlett-Packard, Spacelabs Healthcare, and most recently as Director of Solta Medica in EMEA, Simon is a well-respected leader known for building international sales infrastructures and driving market penetration for advanced technologies. Based in Spain, Simon will lead growth efforts across Europe and Asia for the AYON system and broader Apyx portfolio.
Health Technology Insights: OrbiMed Raises $1.86 Billion for Healthcare Royalty and Credit Fund V
“The addition of John and Simon represents a significant milestone for Apyx as we continue to scale globally and bring groundbreaking solutions to market,” said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical. “Both leaders bring deep industry expertise, commercial acumen, and a shared commitment to elevating patient outcomes through surgical innovation. Their leadership will be pivotal as we launch AYON and shape the future of body contouring.”
“The appointments of John and Simon reflect our ongoing investment in commercial excellence and global expansion. As we enter a new phase of growth with the introduction of AYON, these strategic new hires further position Apyx as a leader in the rapidly evolving aesthetic surgery landscape,” continued Mr. Goodwin.
Health Technology Insights: Delta Development Closes Series A3, Leads Prehospital Blood
To participate in our interviews, please write to our HealthTech Media Room at sudipto@dmintentamplify-com
Source- GlobeNewswire
